These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 31622795)
1. Splicing regulator SRSF1-3 that controls somatic hypermutation of IgV genes interacts with topoisomerase 1 and AID. Kumar Singh A; Tamrakar A; Jaiswal A; Kanayama N; Agarwal A; Tripathi P; Kodgire P Mol Immunol; 2019 Dec; 116():63-72. PubMed ID: 31622795 [TBL] [Abstract][Full Text] [Related]
2. Activation-induced cytidine deaminase (AID)-dependent somatic hypermutation requires a splice isoform of the serine/arginine-rich (SR) protein SRSF1. Kanehiro Y; Todo K; Negishi M; Fukuoka J; Gan W; Hikasa T; Kaga Y; Takemoto M; Magari M; Li X; Manley JL; Ohmori H; Kanayama N Proc Natl Acad Sci U S A; 2012 Jan; 109(4):1216-21. PubMed ID: 22232677 [TBL] [Abstract][Full Text] [Related]
3. SRSF1-3, a splicing and somatic hypermutation regulator, controls transcription of IgV genes via chromatin regulators SATB2, UBN1 and histone variant H3.3. Singh AK; Tamrakar A; Jaiswal A; Kanayama N; Kodgire P Mol Immunol; 2020 Mar; 119():69-82. PubMed ID: 31986311 [TBL] [Abstract][Full Text] [Related]
4. SRSF1-3 contributes to diversification of the immunoglobulin variable region gene by promoting accumulation of AID in the nucleus. Kawaguchi Y; Nariki H; Kawamoto N; Kanehiro Y; Miyazaki S; Suzuki M; Magari M; Tokumitsu H; Kanayama N Biochem Biophys Res Commun; 2017 Apr; 485(2):261-266. PubMed ID: 28235482 [TBL] [Abstract][Full Text] [Related]
5. Topoisomerase I deficiency causes RNA polymerase II accumulation and increases AID abundance in immunoglobulin variable genes. Maul RW; Saribasak H; Cao Z; Gearhart PJ DNA Repair (Amst); 2015 Jun; 30():46-52. PubMed ID: 25869824 [TBL] [Abstract][Full Text] [Related]
6. Decrease in topoisomerase I is responsible for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation. Kobayashi M; Sabouri Z; Sabouri S; Kitawaki Y; Pommier Y; Abe T; Kiyonari H; Honjo T Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19305-10. PubMed ID: 22080610 [TBL] [Abstract][Full Text] [Related]
7. AID preferentially targets the top strand in nucleosome sequences. Singh AK; Jaiswal A; Kodgire P Mol Immunol; 2019 Aug; 112():198-205. PubMed ID: 31176199 [TBL] [Abstract][Full Text] [Related]
8. Unfolding the Role of Splicing Factors and RNA Debranching in AID Mediated Antibody Diversification. Jaiswal A; Singh AK; Tamrakar A; Kodgire P Int Rev Immunol; 2021; 40(4):289-306. PubMed ID: 32924658 [TBL] [Abstract][Full Text] [Related]
9. p21 is dispensable for AID-mediated class switch recombination and mutagenesis of immunoglobulin genes during somatic hypermutation. Shansab M; Selsing E Mol Immunol; 2011 Mar; 48(6-7):973-8. PubMed ID: 21288574 [TBL] [Abstract][Full Text] [Related]
10. DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination. Hackney JA; Misaghi S; Senger K; Garris C; Sun Y; Lorenzo MN; Zarrin AA Adv Immunol; 2009; 101():163-89. PubMed ID: 19231595 [TBL] [Abstract][Full Text] [Related]
11. Necessity of HuR/ELAVL1 for the activation-induced cytidine deaminase-dependent decrease in topoisomerase 1 in antibody diversification. Amin W; Nishio S; Honjo T; Kobayashi M Int Immunol; 2023 Aug; 35(8):361-375. PubMed ID: 37086201 [TBL] [Abstract][Full Text] [Related]
13. Role of activation-induced deaminase protein kinase A phosphorylation sites in Ig gene conversion and somatic hypermutation. Chatterji M; Unniraman S; McBride KM; Schatz DG J Immunol; 2007 Oct; 179(8):5274-80. PubMed ID: 17911613 [TBL] [Abstract][Full Text] [Related]
14. Ago2 and a miRNA reduce Topoisomerase 1 for enhancing DNA cleavage in antibody diversification by activation-induced cytidine deaminase. Kobayashi M; Wakaguri H; Shimizu M; Higasa K; Matsuda F; Honjo T Proc Natl Acad Sci U S A; 2023 May; 120(18):e2216918120. PubMed ID: 37094168 [TBL] [Abstract][Full Text] [Related]
15. Identification of core DNA elements that target somatic hypermutation. Kohler KM; McDonald JJ; Duke JL; Arakawa H; Tan S; Kleinstein SH; Buerstedde JM; Schatz DG J Immunol; 2012 Dec; 189(11):5314-26. PubMed ID: 23087403 [TBL] [Abstract][Full Text] [Related]
17. Restriction of AID activity and somatic hypermutation by PARP-1. Tepper S; Mortusewicz O; Członka E; Bello A; Schmidt A; Jeschke J; Fischbach A; Pfeil I; Petersen-Mahrt SK; Mangerich A; Helleday T; Leonhardt H; Jungnickel B Nucleic Acids Res; 2019 Aug; 47(14):7418-7429. PubMed ID: 31127309 [TBL] [Abstract][Full Text] [Related]
18. Separate domains of AID are required for somatic hypermutation and class-switch recombination. Shinkura R; Ito S; Begum NA; Nagaoka H; Muramatsu M; Kinoshita K; Sakakibara Y; Hijikata H; Honjo T Nat Immunol; 2004 Jul; 5(7):707-12. PubMed ID: 15195091 [TBL] [Abstract][Full Text] [Related]
19. Negative regulation of activation-induced cytidine deaminase in B cells. Muto T; Okazaki IM; Yamada S; Tanaka Y; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2752-7. PubMed ID: 16477013 [TBL] [Abstract][Full Text] [Related]
20. Apurinic/apyrimidinic endonuclease 1 (APE1) is dispensable for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation in the immunoglobulin gene. Islam H; Kobayashi M; Honjo T Int Immunol; 2019 Jul; 31(8):543-554. PubMed ID: 30877298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]